Vulnerability and Risk Committee

AXIS Names Stan Galanski to Its Board of Directors

Retrieved on: 
Monday, December 4, 2023

AXIS Capital Holdings Limited (“AXIS Capital” or “AXIS” or the “Company”) (NYSE: AXS), today announced that it has appointed Stan Galanski to the Company’s Board of Directors.

Key Points: 
  • AXIS Capital Holdings Limited (“AXIS Capital” or “AXIS” or the “Company”) (NYSE: AXS), today announced that it has appointed Stan Galanski to the Company’s Board of Directors.
  • Effective January 1, 2024, Mr. Galanski will join the Board and will serve on its Risk Committee.
  • “Stan is an outstanding addition to our Board of Directors, bringing more than 40 years of experience in the property and casualty space as a public company CEO and with C-Suite roles at leading major and mid-size insurance carriers,” said Henry Smith, Chair of the Board of Directors at AXIS.
  • Over the past six years, the Company has added nine new Directors to the Board (including Mr. Galanski).

Forge Global Announces Transitions to its Board of Directors

Retrieved on: 
Monday, December 4, 2023

Forge Global Holdings, Inc. (“Forge”) (NYSE: FRGE), a leading provider of marketplace infrastructure, data services and technology solutions for private market participants, announced today the appointment of Eric Leupold to its board of directors, effective November 30, 2023.

Key Points: 
  • Forge Global Holdings, Inc. (“Forge”) (NYSE: FRGE), a leading provider of marketplace infrastructure, data services and technology solutions for private market participants, announced today the appointment of Eric Leupold to its board of directors, effective November 30, 2023.
  • “Eric has deep knowledge of and experience with Forge and our market, having served as a member of our board when we were a private company.
  • Mr. Leupold also served on the board of directors for Forge Global, Inc. from July 2021 until the closing of Forge’s business combination in March 2022.
  • Christoph’s and Stephen’s advice and commitment — including in shepherding Forge through its transition to a public company — has benefited Forge immensely,” Mr. Rodriques said.

The Cyber AB Announces Election of New Board Officers

Retrieved on: 
Tuesday, November 28, 2023

The Cyber AB announced today the election of new officers to lead its Board of Directors in 2024-2025.

Key Points: 
  • The Cyber AB announced today the election of new officers to lead its Board of Directors in 2024-2025.
  • Current Board Chairman Jeff Dalton will remain on the Board for the remainder of his current Directorship tenure through 2025 and will enjoy the title of Chairman Emeritus.
  • The new Board officers will assume their duties on January 1, 2024 and serve a two-year term.
  • For more information on The Cyber AB Board, please visit the AB’s website at www.cyberab.org .

FREYR Battery Appoints Jessica Wirth Strine to Board of Directors

Retrieved on: 
Monday, November 27, 2023

FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, has announced the appointment of Jessica Wirth Strine to FREYR’s Board of Directors.

Key Points: 
  • FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, has announced the appointment of Jessica Wirth Strine to FREYR’s Board of Directors.
  • Jessica Wirth Strine, a U.S.-based executive with prior experience as a portfolio manager at BlackRock Inc. (NYSE: BLK) and Vanguard Investments, is joining FREYR’s Board of Directors effective immediately.
  • I wish FREYR and the management all the best in creating a cleaner and more sustainable battery value chain,” remarked Olaug Svarva.
  • “I am delighted to welcome Jessica Wirth Strine to FREYR’s Board of Directors,” commented Tom Einar Jensen, FREYR’s Co-founder and Executive Chairperson.

Seadrill Limited – Results of the 2023 Annual General Meeting of Shareholders

Retrieved on: 
Friday, November 17, 2023

November 17, 2023-- Seadrill Limited (“Seadrill” or the "Company") (NYSE & OSE: SDRL) announces that the 2023 Annual General Meeting of the Shareholders of the Company was held on November 17, 2023 at 09:00, at the Rosewood Hotel, Bermuda.

Key Points: 
  • November 17, 2023-- Seadrill Limited (“Seadrill” or the "Company") (NYSE & OSE: SDRL) announces that the 2023 Annual General Meeting of the Shareholders of the Company was held on November 17, 2023 at 09:00, at the Rosewood Hotel, Bermuda.
  • The audited consolidated financial statements for the Company for the year ended December 31, 2022 were laid before the Meeting.
  • In addition, the following resolutions were passed by shareholders:
    To determine that the number of Directors comprising the Board be set at up to nine (9) Directors until the next annual general meeting of shareholders of the Company, or until such number is changed in accordance with the Bye-laws of the Company.
  • This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

LARRY E. THOMPSON ELECTED CHAIR OF FEDERAL HOME LOAN BANK OF NEW YORK

Retrieved on: 
Thursday, November 16, 2023

NEW YORK, Nov. 16, 2023 /PRNewswire/ -- The Federal Home Loan Bank of New York ("FHLBNY") announced today that Larry E. Thompson has been elected by its Board of Directors ("Board") to serve as Board chair for a two-year term that will commence on January 1, 2024.

Key Points: 
  • NEW YORK, Nov. 16, 2023 /PRNewswire/ -- The Federal Home Loan Bank of New York ("FHLBNY") announced today that Larry E. Thompson has been elected by its Board of Directors ("Board") to serve as Board chair for a two-year term that will commence on January 1, 2024.
  • He is the chair-elect of the Council of Federal Home Loan Banks, which serves as the public voice of the Federal Home Loan Bank System.
  • Mr. Thompson was chair of the Board of DTCC Deriv/SERV LLC and former chair of the DTCC Operating Committee.
  • The Federal Home Loan Bank of New York is a Congressionally chartered, wholesale Bank.

Dutch Bros Inc. Reports Third Quarter 2023 Financial Results and Announces Two New Directors

Retrieved on: 
Tuesday, November 7, 2023

Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”), one of the fastest-growing brands in the food service and restaurant industry in the United States by location count, today reported financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”), one of the fastest-growing brands in the food service and restaurant industry in the United States by location count, today reported financial results for the third quarter ended September 30, 2023.
  • Joth Ricci, Chief Executive Officer of Dutch Bros, stated, “By all accounts, Q3 was a fantastic quarter, and we are extremely pleased with our unit openings, same shop sales, revenue, and profitability results.
  • Dutch Bros is providing the following guidance for the year 2023:
    Our expectation for total system shop openings in 2023 remains unchanged.
  • We will also publish earnings presentation slides related to these financial results on our website https://investors.dutchbros.com under “Events & Presentations”.

Chimera Appoints New Independent Board Member Susan Mills

Retrieved on: 
Wednesday, November 1, 2023

Chimera Investment Corporation (NYSE:CIM) (the “Company” or “Chimera”) announced today that Susan Mills has been elected to the Company’s Board of Directors as a Class I Director, effective November 13, 2023.

Key Points: 
  • Chimera Investment Corporation (NYSE:CIM) (the “Company” or “Chimera”) announced today that Susan Mills has been elected to the Company’s Board of Directors as a Class I Director, effective November 13, 2023.
  • “We are pleased to welcome Ms. Mills to our Board,” said Gerry Creagh, Chairman of the Board.
  • Ms. Mills will stand for election at the Company’s 2024 shareholder meeting for the remaining two years of the Class I Director term.
  • Ms. Mills will serve on the Nominating and Corporate Governance Committee and the Risk Committee of the Company’s Board of Directors.

EQS-News: Quarterly Cashflow Report - Appendix 5b

Retrieved on: 
Friday, October 27, 2023

Note: where item 8.7 is less than 2 quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.

Key Points: 
  • Note: where item 8.7 is less than 2 quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.
  • This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity’s activities for the past quarter, how they have been financed and the effect this has had on its cash position.
  • If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report.
  • If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standards apply to this report.

Actimed Therapeutics Appoints Martin Walton as Chief Financial Officer

Retrieved on: 
Thursday, October 19, 2023

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces the appointment of Martin Walton as Chief Financial Officer.

Key Points: 
  • Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces the appointment of Martin Walton as Chief Financial Officer.
  • Since 2009, Martin has been an active Venture Capital and Private Equity investor, portfolio manager, and advisor in life sciences working with several of the largest investors in the sector.
  • Robin Bhattacherjee, Actimed CEO, commented: “I am delighted to welcome Martin to Actimed, who brings with him a set of highly complementary skills and extensive industry experience.
  • Martin Walton, Actimed CFO commented: “I am excited to be joining Actimed at this important point in the company’s journey to develop the first globally approved product for cancer cachexia.